In honor of International Women’s Day, CURE® compiled some recent news and updates in cancer research that you may have missed.
There have been multiple updates in the field of women’s cancers over the past several months. In honor of International Women’s Day, CURE® looks back at some of the latest news and updates affecting women with breast, ovarian and other women’s cancers.
Dostarlimab shows significant survival benefits in endometrial cancer trial
March 21st 2024GlaxoSmithKline's phase 3 trial demonstrated promising overall and progression-free survival outcomes in patients with primary advanced or recurrent endometrial cancer, paving the way for potential FDA approval.
Read More
Unifying radical hysterectomy classifications with the Querleu-Morrow
February 16th 2024Explore how the latest research underscores the efficacy of the 2017 Querleu-Morrow classification in defining radical hysterectomy extent, shedding light on surgical terminologies for cervical cancer management.
Read More